Bryan Johnson discontinues longevity drug, after concerns it may have accelerated aging
Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following ...
Bonerge Announces the New 108 Person Clinical Trial: Exploring Skin and Organ Anti-Aging ...
Bonerge announced the initiation of its clinical trial, focusing on Fisetin, Urolithin A, and Ergothioneine. Involving 108 ...